Pulpitis - Irreversible Clinical Trial
Official title:
Effect of Intraligmentary Dexamethasone on Anesthetic Efficacy of Inferior Alveolar Nerve Block Versus Buccal Infiltratation in Lower First Molars With Irreversible Pulpitis and Apical Periodontits: A Randomized Clinical Trial
Using intraligmentary dexamethasone to reduce the pain intensity during and after root canal preparation
Status | Not yet recruiting |
Enrollment | 81 |
Est. completion date | September 2024 |
Est. primary completion date | May 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 45 Years |
Eligibility | Inclusion Criteria: 1. Age between 20-45 years old. 2. Systemically healthy patient (ASA I or II). 3. Lower first molar with: - Preoperative sharp pain. - Slight widening in the periodontal ligament (PDL). - Vital response of pulp tissue to cold pulp tester (ethyl chloride spray). Exclusion Criteria: 1. Patients allergic to anesthetics, or dexamethasone (other corticosteroids). 2. Pregnant or nursing females. 3. Patients having significant systemic disorder (ASA III or IV). 4. Hemostatic disorders or anti-coagulant therapy during the last month. 5. Consumption of opioid or non-opioid analgesics or corticosteroids during the last 12 h before treatment. 6. Retreatment cases. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intraoperative pain | Efficacy of buccal infiltration anesthesia and inferior alveolar nerve block measured during procedures of root canal treatment using numerical rating scale.It is a line numbered from 0-10 , where pain levels are categorized as follows: 0= no pain, 1-3 = mild pain, 4-6= moderate pain, 7-10= severe pain, "10" being the most intense pain conceivable.And instruct patient to raise his hand if he feels pain to reasse if he needs supplementary anathesia | During procedure | |
Secondary | Post-operative pain | Patient will record the pain on numerical rating scale (6,12,24 &48h)..It is a line numbered from 0-10 , where pain levels are categorized as follows: 0= no pain, 1-3= mild pain, 4-6= moderate pain, 7-10 = severe pain, "10" being the most intense pain conceivable | After procedure until 48hour | |
Secondary | Number of needed analgesic tablets in case of intolerable pain | Ibuprofen 200mgm tabs have been described to patient in case of sever pain (above6) | After procedure until 48hour |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06268912 -
Cryoanalgesia for Irreversible Pulpitis
|
N/A | |
Completed |
NCT06330519 -
Impact of Different Techniques on The Efficacy of Anaesthesia in Mandibular Molars With Acute Irreversible Pulpitis
|
Phase 4 | |
Recruiting |
NCT05336682 -
Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp
|
N/A | |
Recruiting |
NCT06438523 -
A-prf,Nanochitosan Combined With A-prf Compared to Chitosan for Symptomatic Irreversible Pulpitis of Mature Teeth
|
N/A | |
Recruiting |
NCT03956199 -
Pulpotomy vs.Root Canal Treatment in Managing Irreversible Pulpitis
|
N/A | |
Completed |
NCT03174860 -
Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success
|
Phase 2/Phase 3 | |
Completed |
NCT05853185 -
Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.
|
Phase 4 | |
Not yet recruiting |
NCT03612323 -
Comparison Between Intraligamentary Piroxicam and Articaine
|
Early Phase 1 | |
Not yet recruiting |
NCT02953912 -
Assessment of Postoperative Pain Using Reciproc Versus One Shape Files in Patients With Irreversible Pulpitis
|
N/A | |
Completed |
NCT04308863 -
Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis
|
Phase 2 | |
Completed |
NCT04719247 -
Clinical and Radiographic Evaluation of Turmeric, Thymus Vulgaris, Nigella Sativa and Aloe Vera as Pulpotomy Medicaments in Primary Teeth
|
N/A | |
Completed |
NCT05582317 -
Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars
|
N/A | |
Recruiting |
NCT05402098 -
Outcome Following Endodontic Treatment Using Traditional Access Versus Conservative Access
|
N/A | |
Recruiting |
NCT05406557 -
Partial Versus Miniature Pulpotomy in Teeth With Irreversible Pulpitis
|
N/A | |
Recruiting |
NCT05902936 -
Evaluation of Nano Bioactive Glass Combined With i-PRF Scaffold in Vital Pulp Treatments
|
N/A | |
Recruiting |
NCT03553407 -
Analgesic Effect of Low Intensity Laser in Patients With Pulpitis of Mandibular Molars.
|
N/A | |
Completed |
NCT05904184 -
Comparison of Calcium Silicate-based Sealer and Epoxy Resin-based Sealer
|
Phase 3 | |
Not yet recruiting |
NCT03916900 -
Postoperative Pain and Success Rate in Pulpotomy Versus Root Canal Treatment
|
N/A | |
Completed |
NCT06088446 -
Effect of Intrapulpal Injections on the Post-endodontic Pain
|
N/A | |
Enrolling by invitation |
NCT05964933 -
Pulpotomy vs Root Canal Treatment for Teeth With Symptomatic Irreversible Pulpitis
|
N/A |